We are live on ! Find out more
BYFC icon

Broadway Financial

22 hedge funds and large institutions have $11M invested in Broadway Financial in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more capital inflows, than outflows

Capital inflows: $1.49M | Capital outflows: $325K

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

2.44% more ownership

Funds ownership: 20.82% → 23.27% (+2.4%)

0% more funds holding

Funds holding: 22 → 22 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
10
Reduced
6
Closed
2
Calls
$27K
Puts
–
Net Calls
+$27K
Net Calls Change
+$6K

BYFC Hedge Fund Activity: Q4 2022 in Review

22 of the 6,242 institutional investors tracked by Wall St. Rank reported a position in Broadway Financial (BYFC) for Q4 2022, worth a combined $11M — down 0.13% from $11M a quarter earlier.

Fund positioning in BYFC was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 10 added to existing stakes and 6 trimmed.

The largest buyer was EJF Capital, adding an estimated $1.15M. The largest seller was Bridgeway Capital Management, cutting an estimated $128K.

  • 22 institutional investors held Broadway Financial (BYFC) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $11M of Broadway Financial stock for Q4 2022, down 0.13% quarter-over-quarter.
  • 2 funds opened new Broadway Financial positions in Q4 2022 and 2 closed out, a net change of 0 holders.
  • The largest Broadway Financial buyer in Q4 2022 was EJF Capital, an estimated $1.15M added.
  • The largest Broadway Financial seller in Q4 2022 was Bridgeway Capital Management, an estimated $128K sold.

Based on aggregated 13F filings for Q4 2022.